PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2111130
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2111130
According to Stratistics MRC, the Global Veterinary Consumables Market is accounted for $1.7 billion in 2026 and is expected to reach $3.1 billion by 2034 growing at a CAGR of 7.7% during the forecast period. Veterinary consumables refer to the range of disposable and reusable products used in veterinary practice for diagnosis, treatment, surgery, monitoring, and patient care. These include anesthesia consumables, respiratory and ventilation consumables, monitoring consumables, diagnostic consumables, surgical consumables, wound care consumables, needles and syringes, catheters and cannulas, IV administration consumables, personal protective equipment, sterilization and infection control consumables, and other products. The market serves veterinary hospitals, clinics, specialty centers, and academic institutions. Growing pet ownership, increasing demand for advanced veterinary procedures, rising prevalence of chronic diseases in animals, and expanding veterinary healthcare infrastructure are key drivers of market expansion across all regions.
Increasing pet ownership and demand for advanced veterinary care
The rising global pet population and growing demand for sophisticated veterinary medical care are primary drivers for the veterinary consumables market. Pet owners increasingly consider their animals as family members and are willing to invest in comprehensive diagnostic, surgical, and therapeutic procedures. The humanization of pets has led to greater expectations for quality care, driving demand for consumables used in diagnostics, surgery, monitoring, and patient management. As veterinary practices expand services and specialty care becomes more accessible, consumable consumption increases across all practice types. Growing awareness of preventive healthcare and wellness programs further supports consumable demand, sustaining strong market growth.
High cost of consumables and budget constraints
The significant costs associated with veterinary consumables and limited practice budgets represent a major restraint for the market. Consumables including diagnostic test kits, surgical supplies, and monitoring devices represent ongoing operational costs for veterinary practices. Smaller practices with constrained budgets may limit consumable usage. Price sensitivity in developing regions affects adoption. Pet owners may decline recommended diagnostic tests or procedures due to cost concerns. Limited insurance coverage for veterinary care affects affordability. These cost barriers may limit consumable consumption, particularly among smaller practices and in price-sensitive markets.
Growing demand for point-of-care diagnostic consumables
The increasing adoption of point-of-care diagnostics in veterinary practice presents significant opportunities for veterinary consumables market expansion. Rapid test kits and portable diagnostic devices enable immediate clinical decision-making, improving patient outcomes and practice efficiency. Growing availability of tests for infectious diseases, organ function, and endocrine disorders is expanding point-of-care applications. Pet owner preference for rapid results supports adoption. As technology advances and test menus expand, point-of-care diagnostic consumables capture growing market share, enabling enhanced diagnostic capabilities and practice revenue.
Competition from generic and low-cost alternatives
The availability of generic and low-cost consumable alternatives poses significant threats to branded consumable manufacturers. Generic products may offer cost savings for price-sensitive practices, affecting brand loyalty. Quality concerns with lower-cost alternatives may affect patient outcomes. Practices may switch to lower-cost suppliers to manage operational costs. Online marketplaces increase price transparency and competition. This competition may pressure pricing and margins for consumable manufacturers, particularly in commodity product categories where differentiation is limited.
The COVID-19 pandemic had a significant impact on the veterinary consumables market. Initial disruptions included supply chain interruptions, manufacturing slowdowns, and reduced veterinary visits during lockdowns. However, pet adoption surged during the pandemic, expanding the patient population. Veterinary practices adapted with enhanced infection control protocols, increasing PPE and sterilization consumable demand. Telemedicine and remote consultations expanded. Post-pandemic, elevated pet ownership and continued focus on pet health have sustained consumable demand. The crisis reinforced the importance of infection control and preventive care.
The Surgical Consumables segment is expected to be the largest during the forecast period
The Surgical Consumables segment is expected to account for the largest market share during the forecast period, driven by the high volume of surgical procedures performed in veterinary practice and the essential nature of consumables including surgical gloves, drapes, sutures, and staplers and clips. Surgical consumables are required for every surgical procedure, representing consistent demand across general and specialty practices. The segment benefits from growing surgical caseloads, increasing complexity of veterinary surgeries, and emphasis on infection control and aseptic technique. As veterinary surgical capabilities expand and procedure volumes grow, surgical consumables maintain the largest product segment share throughout the forecast period.
The Disposable segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Disposable segment is predicted to witness the highest growth rate, fueled by increasing emphasis on infection control, convenience, and reduced risk of cross-contamination. Disposable consumables eliminate cleaning, sterilization, and reprocessing requirements, reducing practice labor costs and infection risks. The segment benefits from growing awareness of hospital-acquired infections and implementation of infection control protocols. Demand for single-use products including syringes, gloves, and diagnostic kits is expanding. Advances in disposable product technology are improving performance and reducing environmental impact. As infection control priorities intensify, disposable consumables deliver the fastest segment growth.
During the forecast period, the North America region is expected to hold the largest market share, supported by high pet ownership rates, strong spending on veterinary care, and advanced veterinary healthcare infrastructure. The United States leads regional market growth with substantial investment in veterinary consumables across all product categories. High procedure volumes and advanced diagnostic, surgical, and monitoring capabilities drive consumable consumption. Strong presence of consumable manufacturers and distributors supports market accessibility. Established veterinary practice networks create consistent demand. With high pet spending and advanced veterinary infrastructure, North America maintains its dominant market position.
Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, driven by rising pet ownership, increasing disposable incomes, and growing awareness of advanced veterinary care across countries including China, India, Australia, and Southeast Asia. The region's rapidly growing pet population and expanding middle class create substantial demand for veterinary consumables. Veterinary practice modernization and technology adoption are accelerating. Growing availability of veterinary consumables through expanding distribution networks supports accessibility. As veterinary healthcare develops and procedure volumes increase, Asia Pacific delivers the fastest veterinary consumables market growth globally.
Key players in the market
Some of the key players in Veterinary Consumables Market include Covetrus, Inc., Patterson Companies, Inc., Henry Schein, Inc., Medtronic plc (Veterinary Consumables Portfolio), B. Braun SE, ICU Medical, Inc., Millpledge Veterinary, Jorgen Kruuse A/S, Neogen Corporation, IDEXX Laboratories, Inc., Virbac S.A., Zoetis Inc., Vetland Medical Sales & Services, Dispomed Ltd., MWI Animal Health, and Narang Medical Limited.
In May 2026, Covetrus and MWI Animal Health (a subsidiary of Cencora) announced a definitive merger agreement to form a global animal health distribution, technology, and consumables services provider.
In March 2026, Zoetis entered into a definitive agreement to acquire Neogen Corporation's animal genomics business (GeneSeek) for $160 million, expanding its Precision Animal Health and predictive diagnostic solutions for livestock producers.
In January 2026, Patterson Veterinary acquired full sole ownership of NaVetor, a cloud-based veterinary practice management software, and launched a major update featuring automated two-way texting, enhanced workflow integration, and patient search capabilities.
In June 2025, IDEXX expanded its Catalyst in-clinic diagnostic testing menu with the commercial launch of the Catalyst Cortisol Test, providing quantitative measurements to evaluate canine endocrine disorders like Addison's disease and Cushing's syndrome.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.